Press release
Global Systemic Aspergillosis And Systemic Candidiasis Market 2024 Competitive Landscape, Industry Analysis, Segmentation And Forecast To 2033
Systemic Aspergillosis And Systemic Candidiasis Market
The Business Research Company offers in-depth market insights through Systemic Aspergillosis And Systemic Candidiasis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The systemic aspergillosis and systemic candidiasis market size has grown strongly in recent years. It will grow from $6.82 billion in 2023 to $7.2 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing incidence of fungal infections, immunocompromised patient population, improved diagnostic technologies, rise in invasive medical procedures, global spread of infections.
The systemic aspergillosis and systemic candidiasis market size is expected to see steady growth in the next few years. It will grow to $8.63 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to global antifungal resistance surveillance, aging population, telemedicine for remote consultations, patient-centric drug development, digital health solutions for patient management. Major trends in the forecast period include new fungal biomarkers for early detection, emergence of novel antifungal agents, advancements in immunotherapy, innovative drug delivery systems.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12148&type=smp
Market Segmentation:
The systemic aspergillosis and systemic candidiasis market covered in this report is segmented -
1) By Type: Systemic Oral Azoles, Voriconazole, Liposomal Amphotericin B, Topical Antifungal Agents, Other Types
2) By Application: Allergic Bronchopulmonary Aspergillosis (ABPA), Chronic Pulmonary Aspergillosis (CPA), Gastrointestinal Candidiasis, Genitourinary Tract Candidiasis, Other Applications
3) By End User: Clinic, Hospital, Other End Users
Major Driver - Rising Incidence Of Fungal Diseases Spurs Growth In The Systemic Aspergillosis And Systemic Candidiasis Market
The increase in the incidence of fungal diseases is expected to propel the growth of the systemic aspergillosis and systemic candidiasis market going forward. Fungal diseases refer to infections caused by fungi that can affect various body parts, resulting in multiple symptoms and complications. These diseases include cutaneous skin infections, respiratory infections, and systemic infections. Fungal diseases are treated with antifungal medications such as oral azoles, voriconazole, and liposomal amphotericin B. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, in the US, the clinical cases of Candida auris, an emerging fungus, increased from 476 in 2019 to 1,471 in 2021. Screening cases increased threefold from 2020 to 2021, to 4,041. Therefore, the increase in the incidence of fungal disease is driving the growth of the systemic aspergillosis and systemic candidiasis market.
Competitive Landscape:
Major companies operating in the systemic aspergillosis and systemic candidiasis market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Matinas BioPharma Holdings Inc., Shionogi & Co. Ltd, Cipla Limited, Taj Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Cidara Therapeutics Inc., T2 Biosystems Inc., Sandoz International GmbH, Grupo Ferrer International S.A., Entasis Therapeutics Inc., NovaDigm Therapeutics Inc., F2G Ltd., Mycovia Pharmaceuticals Inc., ContraFect Corporation, Enzon Pharmaceutical Inc., Pacgen Life Science Corporation, Biosergen AS, N8 Medical LLC
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/systemic-aspergillosis-and-systemic-candidiasis-global-market-report
Top Trend - Product Innovation Drive Advancements In The Systemic Aspergillosis And Systemic Candidiasis Markets
Product innovation is a key trend gaining popularity in the systemic aspergillosis and systemic candidiasis markets. Major companies operating in the systemic aspergillosis and systemic candidiasis markets are focused on developing innovative products to sustain their position in the market. For instance, in October 2021, Intas Pharmaceuticals Limited, an India-based pharmaceutical formulation development, manufacturing, and marketing company, launched the world's first Super Bioavailable Itraconazole-SB 100mg under the brand name Itaspor-SB Forte/Subawin. It will cut the dosing in half, and patients can consume it with or without food, with just water. The conventional Itraconazole mainstay medicine to combat fungal infection has a large outcome variance and low patient compliance.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Systemic Aspergillosis And Systemic Candidiasis Market Characteristics
3. Systemic Aspergillosis And Systemic Candidiasis Market Trends And Strategies
4. Systemic Aspergillosis And Systemic Candidiasis Market - Macro Economic Scenario
5. Systemic Aspergillosis And Systemic Candidiasis Market Size And Growth
…..
27. Systemic Aspergillosis And Systemic Candidiasis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Systemic Aspergillosis And Systemic Candidiasis Market 2024 Competitive Landscape, Industry Analysis, Segmentation And Forecast To 2033 here
News-ID: 3432225 • Views: …
More Releases from The Business research company
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Systemic
Transformative Trends Impacting the Systemic Aspergillosis And Systemic Candidia …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Systemic Aspergillosis And Systemic Candidiasis Market Size By 2025?
The growth trend of the systemic aspergillosis and systemic candidiasis market has been steadily ascending in the past few years. The market size will inflate from $7.24 billion in 2024 to $7.59 billion in 2025, indicating…
Systemic Aspergillosis And Systemic Candidasis Market Size by Type, Application, …
According to Market Research Intellect, the global Systemic Aspergillosis And Systemic Candidasis market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The growing prevalence of invasive fungal infections, especially in immunocompromised persons, is propelling the global…
Systemic Aspergillosis and Systemic Candidiasis Treatment Market - Industry Over …
The systemic aspergillosis and systemic candidiasis treatment market is gaining significant attention within the global healthcare and pharmaceutical industries due to the increasing incidence of life-threatening fungal infections among immunocompromised individuals. Both systemic aspergillosis and systemic candidiasis are opportunistic fungal infections, often affecting patients with weakened immune systems due to cancer therapy, organ transplantation, HIV/AIDS, or intensive care treatments.
The systemic aspergillosis and systemic candidiasis treatment market was valued at approximately…
Europe Systemic Aspergillosis and Systemic Candidasis Market Comprehensive Analy …
The Europe systemic aspergillosis and systemic candidasis market is expected to reach US$ 2,237.55 million by 2027 was Valued at US$ 1,702.60 million in 2019; it is estimated to grow with a CAGR of 3.5% from 2020 to 2027.
The "Europe Systemic Aspergillosis and Systemic Candidasis Market" forecast 2027 report analyses the present and future competitive scenario of the analytics industry. Europe Systemic Aspergillosis and Systemic Candidasis Market report offers an…
Systemic Aspergillosis and Systemic Candidiasis Market Share, Sales Channels and …
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The systemic aspergillos is and systemic candidiasis market is expected to reach US$ 8,247.5 million by 2027 from US$ 6,056.3 million in 2019. The market is estimated to grow at a CAGR of 4.0% from 2020 to 2027.
To get sample Copy of the report, along with…
Systemic Aspergillosis and Systemic Candidiasis Treatment Market Insight & Futur …
(Portland, United States): Avail a detailed research offering a comprehensive analysis of the developments, growth outlook, driving factors, and key players of the Systemic Aspergillosis and Systemic Candidiasis Treatment Market in the latest research report added by Big Market Research. The recent research report on the global Systemic Aspergillosis and Systemic Candidiasis Treatment Market presents the latest industry data and future trends, allowing you to recognize the products and end…
